No spam - just the good stuff
Subscribe to our newsletter
First Name
(Required)
Email Address
(Required)
Hidden
Contact Source
News
Investor Portal
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
Will psychedelics produce the next longevity drug?
Dr Halland Chen on longevity medicine, mindset and the potential of psychedelics to improve human longevity.
Innovation
Genflow makes progress towards clinical trial of NASH gene therapy
Biotech
‘It’s always too early to say something’s impossible’
Videos
‘We are information machines – and it’s time to renew the code.’
Investment
Investment
Videos
VitaDAO and GlycanAge explore longevity and DeSci in Abu Dhabi event
Economy
FDA clears AI tool for early Alzheimer’s detection from MRI scans
AI/Digital
Diagnostics
Venture firm age1 launches with $35 million to extend healthy lifespan
Investment
Investment
Broken String snags $15 million to make cell and gene therapy safer
Investment
Investment
New panel set to aid detection of inflammation and biological stress biomarkers
Diagnostics
New study reveals how neurons die in Alzheimer’s disease
Innovation
NMN Bio and Aster Pharmacy unite to bring antiaging supplements to UAE market
Investment
Investment
Supplements
FDA greenlights Beacon’s AI-assisted sleep monitoring device
AI/Digital
Leveraging the past to illuminate longevity for the future
Features
Innovation
Investment
Investment
Most Popular
Longevity investment bulletin: NewLimit, ORA, Insilico Medicine and more
Investment
Investment
Stay cool: the longevity tech that “shows insane promise”
Features
Videos
Does SIRT6 hold the key to human longevity?
Biotech
Tally up! Consumer longevity company lands $10m
Diagnostics
Investment
Investment
Innovation
Will psychedelics produce the next longevity drug?
Dr Halland Chen on longevity medicine, mindset and the potential of psychedelics to improve human longevity.
New study reveals how neurons die in Alzheimer’s disease
Breakthrough research illustrates how neurons initiate a programmed form of cell death – and how neuron death can be prevented.
Leveraging the past to illuminate longevity for the future
Rooted in Amish genetic knowledge, Zoe Biosciences’ novel platform could become the gold standard for delayed human aging.
First-ever clinical trial of ketone supplementation to treat and prevent frailty
$3.5m NIH grant funds multi-site trial to see if putting at-risk older adults into ketosis can stave off a key aspect of geriatric syndrome.
Economy
VitaDAO and GlycanAge explore longevity and DeSci in Abu Dhabi event
Longevity.Technology announces entry into Asia Pacific markets
Ending Aging Forum 2023
Longevity on the rise
Treat the mind, treat the body: Addressing a fundamental gap in acute disease management
Wonderland Conference expands into longevity and mental health
Supplements
NMN Bio and Aster Pharmacy unite to bring antiaging supplements to UAE market
Partnership aims to set a new standard for health and wellness in the United Arab Emirates.
Supplements
First-ever clinical trial of ketone supplementation to treat and prevent frailty
Supplements
Thorne to be acquired by L Catterton for $680 million in cash
Supplements
Researchers develop compound that prevents free radical production in mitochondria
Supplements
Avea secures $5 million in seed funding
Supplements
Longevity: This time it’s personal
Supplements
Taurine deficiency: New research identifies possible driver for aging
Supplements
A strong patent portfolio delivers a competitive edge in the longevity space
Supplements
Combilytics: Taking a combined approach to senescence
Supplements
Editor's pick
‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’
Features
Videos
Calling all longevity clinicians: your voice matters!
Diagnostics
Combining AI and MRI to improve human longevity
AI/Digital
Diagnostics
Andrew Steele: Curing aging is a question of investment, not time
Features
Investment
Investment
Investment
‘We are information machines – and it’s time to renew the code.’
Methuselah Foundation's CEO David Gobel on clinging to the longevity biotech mast while waiting for the rising tide.
Venture firm age1 launches with $35 million to extend healthy lifespan
Dr Alex Colville joins forces with Laura Deming to advance The Longevity Fund’s mission and lead investments in longevity science moonshots.
Broken String snags $15 million to make cell and gene therapy safer
INDUCE-seq platform aims to enable the development of CRISPR cell and gene therapies that are 'safer by design.'
NMN Bio and Aster Pharmacy unite to bring antiaging supplements to UAE market
Partnership aims to set a new standard for health and wellness in the United Arab Emirates.
Diagnostics
FDA clears AI tool for early Alzheimer’s detection from MRI scans
New panel set to aid detection of inflammation and biological stress biomarkers
Sonera exits stealth with $11m for neural sensing chip technology
New blood test detects key indicator of Parkinson’s disease
Viome lands $86.5m and US retail deal for gut health test
Dialing up human longevity
Watch now
‘We are information machines – and it’s time to renew the code.’
Methuselah Foundation's CEO David Gobel on clinging to the longevity biotech mast while waiting for the rising tide.
Videos
‘It’s always too early to say something’s impossible’
Videos
‘We’re at the longevity inflection point – and the explosion is coming.’
Videos
Longevity to a sirtuin extent
Videos
‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’
Videos
Longevity: This time it’s personal
Videos
SIRT6: The protein that talks the talk and walks the walk
Videos
Navigate the emerging field of longevity
Videos
It’s a brave new world – but longevity needs to stay in the realm of the credible
Videos
Agetech
Connected technologies are changing the future of aging at home
Huong Le Dieu, Lead Product Manager of BLabs at Baracoda Daily Healthtech, on why it's time to take aging in place to the next level.
AI innovations to transform living with dementia awarded £1.9 million
Longitude Prize on Dementia champions personalized tech that to helps people living with dementia enjoy independent and fulfilled lives.
Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech
Definitive merger agreement set to accelerate robotic companion care/AI longevity tech platform to market.
Large study finds brain training can reduce falls in older adults
It's fall in your head – new 10-year study using BrainHQ data demonstrates brain training reduces fall risk.
Biotech
Genflow makes progress towards clinical trial of NASH gene therapy
The quest for rejuvenation without reprogramming
Nine Square Therapeutics lands $4.5m to advance development of novel Parkin activators
Rejuveron lands $75m to advance healthy aging portfolio; expands focus in Middle East
Alnylam drug shown to reduce blood pressure in Phase 2 trial
Telomere-boosting mRNA therapeutic turns back the aging clock
AI/Digital
FDA clears AI tool for early Alzheimer’s detection from MRI scans
FDA greenlights Beacon’s AI-assisted sleep monitoring device
Carenostics raises $5m for AI-powered chronic disease diagnosis
Generative AI company lands $100m to develop ‘biological software’